Medical device company SentreHEART has racked up $26 million in a Series C round, bringing its total venture funding up to $36.4 million. New investor Vivo Ventures led the round, and existing investors US Venture Partners and Prospect Venture Partners also participated. SentreHEART specializes in developing soft tissue closure products with catheter-based technology, including the LARIAT Suture Delivery Device, which doesn't require a metal implant or clip being left behind.
